MX351846B - Preparacion de suero. - Google Patents

Preparacion de suero.

Info

Publication number
MX351846B
MX351846B MX2013003116A MX2013003116A MX351846B MX 351846 B MX351846 B MX 351846B MX 2013003116 A MX2013003116 A MX 2013003116A MX 2013003116 A MX2013003116 A MX 2013003116A MX 351846 B MX351846 B MX 351846B
Authority
MX
Mexico
Prior art keywords
serum preparation
clotting compositions
pathology
clotting
high quality
Prior art date
Application number
MX2013003116A
Other languages
English (en)
Other versions
MX2013003116A (es
Inventor
Masci Paul
De Jersey John
Lavin Martin
Phillips Julie
Dimeski Goce
Original Assignee
Q Sera Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010904233A external-priority patent/AU2010904233A0/en
Application filed by Q Sera Pty Ltd filed Critical Q Sera Pty Ltd
Publication of MX2013003116A publication Critical patent/MX2013003116A/es
Publication of MX351846B publication Critical patent/MX351846B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al uso de una composición de coagulación en la preparación de una muestra de suero de detección de analito, en donde la composición de coagulación consiste esencialmente de activador de protrombina purificado o comprende activador de protrombina purificado o parcialmente purificado de veneno de serpiente.
MX2013003116A 2010-09-20 2011-09-20 Preparacion de suero. MX351846B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010904233A AU2010904233A0 (en) 2010-09-20 Serum Preparation
PCT/AU2011/001221 WO2012037609A1 (en) 2010-09-20 2011-09-20 Serum preparation

Publications (2)

Publication Number Publication Date
MX2013003116A MX2013003116A (es) 2013-08-29
MX351846B true MX351846B (es) 2017-10-31

Family

ID=45873310

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013003116A MX351846B (es) 2010-09-20 2011-09-20 Preparacion de suero.

Country Status (15)

Country Link
US (2) US10385381B2 (es)
EP (1) EP2619540B1 (es)
JP (2) JP6133777B2 (es)
KR (1) KR102098083B1 (es)
CN (2) CN107870246B (es)
AU (2) AU2011305058A1 (es)
BR (1) BR112013006444B8 (es)
CA (1) CA2811822C (es)
DK (1) DK2619540T3 (es)
ES (1) ES2674177T3 (es)
IL (1) IL225346B (es)
MX (1) MX351846B (es)
RU (1) RU2643957C2 (es)
WO (1) WO2012037609A1 (es)
ZA (1) ZA201302160B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103513023A (zh) * 2012-06-20 2014-01-15 江苏英诺华医疗技术有限公司 一种以edta抗凝血进行凝血相关功能检测的方法
CA3002250C (en) 2014-10-23 2024-02-06 Q-Sera Pty Ltd Improved clotting composition
WO2016137431A1 (en) * 2015-02-23 2016-09-01 Nantpharma, Llc Robust methods for determining heparin concentrations
CA3005026A1 (en) * 2015-11-11 2017-05-18 Ethicon, Inc. Sealant formulation and uses thereof
ITUB20160205A1 (it) * 2016-02-05 2017-08-05 Andrea Dominijanni Metodo di preparazione di sangue periferico per l’ottenimento di un preparato con alte concentrazioni di fattori di crescita
CN106248919B (zh) * 2016-07-15 2018-11-06 重庆鼎润医疗器械有限责任公司 基于血样振动检测凝血状态的方法
CN106404483A (zh) * 2016-08-31 2017-02-15 上海科华生物工程股份有限公司 一种血清的制备方法
EP3427833A1 (en) * 2017-07-10 2019-01-16 Victor Lind A device for test preparation of blood for determination of glucose concentration in blood plasma
CN110501504B (zh) * 2018-05-16 2024-03-12 深圳市理邦精密仪器股份有限公司 血液含量检测方法和系统
US20210215724A1 (en) * 2020-01-10 2021-07-15 Oklahoma Blood Institute Method of treating plasma for use
IL273876B2 (en) * 2020-04-07 2024-02-01 Reddress Ltd A method and system for creating a coagulated blood-based dressing, and a connection device that enables this

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142561A (en) * 1981-02-28 1982-09-03 Masaaki Makino Blood coagulation promoting agent for serum separation and its manufacture
SU1146002A1 (ru) * 1983-07-13 1985-03-23 Алтайский государственный медицинский институт им.Ленинского комсомола Способ количественного определени фибриногена в плазме крови
JPS6153567A (ja) * 1984-08-24 1986-03-17 Nippon Hebizoku Gakujiyutsu Kenkyusho ヒメハブ毒からの血清分離用血液凝固促進剤の製造法
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5089415A (en) * 1990-09-17 1992-02-18 International Technidyne Corp. Method for clotting heparized blood by the addition of protamine, thrombin and snake venom
JPH05157747A (ja) * 1991-12-06 1993-06-25 Nissho Corp 採血管
EP0585504A1 (en) * 1992-09-04 1994-03-09 Pentapharm A.G. Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing
US5736033A (en) 1995-12-13 1998-04-07 Coleman; Charles M. Separator float for blood collection tubes with water swellable material
JP3401162B2 (ja) 1996-11-21 2003-04-28 積水化学工業株式会社 血液凝固促進剤及び血液検査用容器
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
JP2000033081A (ja) * 1998-05-13 2000-02-02 Sekisui Chem Co Ltd 血液検査用容器
JP2000046825A (ja) * 1998-05-26 2000-02-18 Sekisui Chem Co Ltd 血液検査用容器
JP2000070241A (ja) * 1998-08-31 2000-03-07 Nissho Corp 急速凝固用真空採血管
JP2000083934A (ja) 1998-09-14 2000-03-28 Medical Link Kk 採血管
US6562837B1 (en) * 1998-10-21 2003-05-13 Korea Institute Of Science & Technology Use of tetrahydroisoquinoline compounds for the treatment of septicemia
JP2001289842A (ja) * 2000-04-10 2001-10-19 Sekisui Chem Co Ltd 血液検査用容器
US6686204B2 (en) * 2001-08-27 2004-02-03 Becton, Dickinson & Company Collection device
BRPI0200269B1 (pt) * 2002-01-31 2016-07-26 Ana Marisa Chudzinski-Tavassi processo de purificação de proteínas solúveis das cerdas da l. obliqua com atividade ativadora de protrombina e uso da fração proteica
US7745192B2 (en) * 2002-04-03 2010-06-29 Venomics Pty Limited Prothrombin activating protein
US20080086085A1 (en) * 2004-05-03 2008-04-10 Leroy Brown Blood drawing device with flash detection
US20090180995A1 (en) * 2005-08-05 2009-07-16 National University Of Singapore Novel anticoagulant polypeptides and complex
UA14516U (en) 2005-11-30 2006-05-15 Nat Univ Food Technologies Vacuum-apparatus for crystallization of solutions
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
CN101173003A (zh) * 2006-11-03 2008-05-07 中国科学院上海生命科学研究院 尖吻蝮蛇毒凝血酶原激活剂、其编码序列及用途
WO2009079690A1 (en) * 2007-12-20 2009-07-02 The University Of Queensland Haemostasis- modulating compositions and uses therefor
CN101614736A (zh) * 2008-06-27 2009-12-30 北京华大吉比爱生物技术有限公司 应用新型全血样品垫处理方法的免疫层析检测试剂盒
EP2320208B1 (en) * 2008-08-28 2013-10-16 Sekisui Medical Co., Ltd. Blood collection container
CN201356558Y (zh) * 2009-01-21 2009-12-09 威海鸿宇医疗器械有限公司 中空加胶真空采血管

Also Published As

Publication number Publication date
RU2013118341A (ru) 2014-10-27
CA2811822C (en) 2019-12-03
JP6419886B2 (ja) 2018-11-07
ZA201302160B (en) 2019-06-26
US20130273584A1 (en) 2013-10-17
EP2619540A1 (en) 2013-07-31
ES2674177T3 (es) 2018-06-27
KR102098083B1 (ko) 2020-04-08
IL225346B (en) 2020-09-30
MX2013003116A (es) 2013-08-29
WO2012037609A1 (en) 2012-03-29
CN103403519B (zh) 2018-02-02
RU2643957C2 (ru) 2018-02-06
CA2811822A1 (en) 2012-03-29
BR112013006444A8 (pt) 2019-04-16
AU2015238915B2 (en) 2017-07-20
DK2619540T3 (en) 2018-06-25
EP2619540A4 (en) 2014-04-09
US10385381B2 (en) 2019-08-20
BR112013006444A2 (pt) 2016-07-26
US20190390248A1 (en) 2019-12-26
CN107870246A (zh) 2018-04-03
AU2011305058A1 (en) 2013-05-02
KR20140014071A (ko) 2014-02-05
JP2013537308A (ja) 2013-09-30
BR112013006444B8 (pt) 2021-03-09
AU2015238915A1 (en) 2015-10-29
BR112013006444B1 (pt) 2020-12-15
CN107870246B (zh) 2021-04-09
EP2619540B1 (en) 2018-03-21
JP2017161539A (ja) 2017-09-14
JP6133777B2 (ja) 2017-05-24
CN103403519A (zh) 2013-11-20
IL225346A0 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
MX351846B (es) Preparacion de suero.
AU2016204248A1 (en) Boron-Containing Molecules
GB201020995D0 (en) Biological materials and uses thereof
MX356508B (es) Preparacion de muestras de acido nucleico.
GB2511221A (en) Methods and compositions for classification of samples
WO2010132453A3 (en) Methods and compositions for analyte detection
GB201014805D0 (en) Microfluidics based assay device
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
MX347020B (es) Anticuerpo contra el csf-1r.
MA33256B1 (fr) Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
NZ701791A (en) Cell culture compositions and methods for polypeptide production
AU2013228077B2 (en) Composition for hot-start reverse transcription reaction or hot-start reverse transcription polymerase chain reaction
IN2015DN02793A (es)
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
MX2017004213A (es) Anticuerpo anti-repeticiones de dipeptido (dpr) derivados de humano.
EA201590312A1 (ru) Ферменты
WO2012003402A3 (en) Compositions and methods for culturing microorganisms
UA112755C2 (uk) Метод лікування синдрому дефіциту уваги і гіперактивності
BR112015014961A8 (pt) métodos para preparação de composições de mistura de líquidos biológicos e para a remoção de solvente-detergente (s/d) a partir de uma fonte biológica, as referidas composições, recipiente e kit compreendendo as mesmas
EA201390467A1 (ru) Композиции антител и способы применения
LT2013016A (lt) Aktyvuotos-potencijuotos formos antikūno poveikio padidinimo būdas
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
PH12014501176A1 (en) Anticoagulant reversal agents
EA201400683A1 (ru) Стабильные композиции sns-595 и способы их получения

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: Q-SERA PTY LTD

FG Grant or registration